AzTrials
AzTrials

HealthyMTRFNCT04944745

Myofascial Release of the Pectoral Fascia

A study testing Myofascial Release in people with Healthy, run by University of Manitoba at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Neck-shoulder pain is among the most common health care problems, especially in office workers and females. Forward shoulder posture (FSP) is a common postural deviation and known risk factor for the development of neck-shoulder pain and pathology. Read more about this study

Who is it for?
Ages 18 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Healthy
What is being tested?
Myofascial Release
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
60 participants
Where
1 siteCanada
Study dates
14 Oct 2020to 6 Nov 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • have 1 cm of anterior deviation of the acromion process (forward shoulder posture)
  • right handed

Who cannot join

  • recent history (<6 months) of neck, shoulder, or upper back pain
  • recent history (<6 months) of neck, shoulder, or upper back injury/pathology
  • history of orthopaedic or neurological disorders

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • University of Manitoba

    Winnipeg, Manitoba, R3T2N2

Other trials in Canada

About this study

Official title: Myofascial Release of the Pectoral Fascia: Effect on Shoulder Posture, Muscle Length, Muscle Activity, and Movement Performance

Neck-shoulder pain is among the most common health care problems, especially in office workers and females. Forward shoulder posture (FSP) is a common postural deviation and known risk factor for the development of neck-shoulder pain and pathology. Common approaches for reducing FSP include stretching and performing manual techniques to increase the length and extensibility of the scapular protractors, and strengthening the scapular retractors. Myofascial release (MFR) is a group of manual techniques that elongate and soften restricted fascia, however, the effects of myofascial release to the pectorals on FSP are currently unknown. The objectives of this study are to determine the impact of 4-minutes of MFR on: 1) FSP, 2) pectoral length, 3) muscle activity of the upper, middle, and lower trapezius and pectoralis major, 4) scapular retractor to protractor ratio of activity, and 4) movement performance compared to a soft-touch control. We hypothesize that MFR will: 1) decrease FSP, 2) increase pectoral length, 3) increase upper, middle, and lower trapezius activity and decrease pectorals major activity, 4) increase the scapular retractor to protractor ratio of activity, and 4) improve movement performance.

Conditions
Healthy
Being tested
Myofascial Release, Soft-touch Control

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Myofascial ReleaseOther

    Moderate pressure manual treatment to the pectoral fascia.

  • Soft-touch ControlOther

    No pressure manual treatment to the pectoral fascia.

Study groups in NCT04944745
Study groupRoleWhat they receive
Myofascial release (MFR)ExperimentalThe pectoral MFR will be completed by an experienced registered massage therapist (RMT). They will stand on the participant's right side slightly rotated to the left facing towards the participant's left hip and apply a cross-hand MFR technique to the superficial pectoral fascia on the right side. The therapist will begin by placing the distal region of the anterior palm of the anchoring hand (therapist's right hand) on the right edge of the anterior sternum at the level of the 3rd to the 6th ribs on the skin and the draping over the pectoral fascia. They will then apply a gentle posterior pressure to hold the fascia in place. The forearm of the mobilizing hand (RMT's left hand) will be directed to the right shoulder wit hate right forearm crossing over the left and the contact of are of the mobilizing hand will be the skin superficial to the pectoral fascia and insertion of pectorals major on the anterior aspect of the humerus. This will be held for four minutes.
Receives: Other: Myofascial Release
Soft-touch Control (CON)Sham comparatorThis control treatment will be set up the same way in regards to the RMT's hand placement, except no pressure will be applied. The RMT's hands will simply be resting over the contact points. This treatment will also be held for four minutes.
Receives: Other: Soft-touch Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Forward shoulder posture after intervention

    Relative- photographic analysis. Participant stand in a relaxed position and have a photo taken from their side where an online program will be used to quantify their forward shoulder posture

    Measured: 30-minutes

  2. Change in Forward shoulder posture after intervention

    Absolute measurements taken- double square method. Participants will stand with their back against the wall and the tool will measure the distance from the wall to their acromion process.

    Measured: 30-minutes

  3. Change in Pectoral Length after intervention

    Measured passive horizontal abduction of the shoulder

    Measured: 30-minutes

  4. Change in Muscle Activity- Upper Trapezius after intervention

    sEMG during a reaching task

    Measured: 30-minutes

  5. Change in Muscle Activity- Middle Trapezius after intervention

    sEMG during a reaching task

    Measured: 30-minutes

  6. Change in Muscle Activity- Lower Trapezius after intervention

    sEMG during a reaching task

    Measured: 30-minutes

  7. Change in Muscle Activity- Pectoralis Major after intervention

    sEMG during a reaching task

    Measured: 30-minutes

  8. Change in Movement performance- reaction time after intervention

    Participants will complete a reaching task using custom designed software (E-Prime). The reaching task is a modified Fitts' Task where the participant must reach towards one of five randomly appearing targets.

    Measured: 30-minutes

  9. Change in Movement performance- movement time after intervention

    Participants will complete a reaching task using custom designed software (E-Prime). The reaching task is a modified Fitts' Task where the participant must reach towards one of five randomly appearing targets.

    Measured: 30-minutes

  10. Change in Movement performance- accuracy after intervention

    Participants will complete a reaching task using custom designed software (E-Prime). The reaching task is a modified Fitts' Task where the participant must reach towards one of five randomly appearing targets.

    Measured: 30-minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jun 2021
  2. Study start14 Oct 2020
  3. Primary completion6 Nov 2021
  4. Study completion6 Nov 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
Single blind between subjects repeated measures crossover design
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04944745
Sponsor's protocol ID
50187
Acronym
MTRF
Status last verified
Mar 2022
First submitted
2 Jun 2021
Last updated
7 Mar 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Chimera NJ, Bohunicky S, Glazebrook C, Scribbans T. Postural factors contributing to reaching speed and accuracy. Int J Occup Saf Ergon. 2025 Sep;31(3):903-912. doi: 10.1080/10803548.2025.2466919. Epub 2025 Mar 10.

    PubMed 40062388

Questions about this trial

What is this clinical trial studying?

A study testing Myofascial Release in people with Healthy, run by University of Manitoba at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Mar 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Forward shoulder posture after intervention (time frame: 30-minutes). The study lists 10 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04944745, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Mar 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Myofascial Release of the Pectoral Fascia | AzTrials